84 articles
Agnes B. Fogo
Agnes B. Fogo, also published as Agnes Fogo, is an American nephropathologist at Vanderbilt University Medical Center who co-authored the lupus nephritis and FSGS classification systems.
Albert L. Rubin
Albert L. Rubin is an American physician-scientist in nephrology and kidney transplantation at Cornell University Medical College who founded The Rogosin Institute and performed the metropolitan area's first hemodialysis and kidney transplant.
Alfred F. Michael
Alfred F. Michael (1928–2022) was an American pediatric nephrologist at the University of Minnesota known for applying immunologic methods to kidney disease and building a leading pediatric kidney program.
Ali G. Gharavi
Ali G. Gharavi is an American nephrologist and human geneticist who chairs medicine at Columbia, known for finding genes for IgA nephropathy and congenital kidney disease.
Andreas Linkermann
Andreas Linkermann is a German nephrologist and transplantation physician known for research on necroptosis and ferroptosis in acute kidney injury, chair of Nephrology at Heidelberg University since 2024.
Ariela Benigni
Ariela Benigni, born 1955 in Bergamo, is an Italian biologist and nephrology researcher at the Mario Negri Institute, known for work on kidney disease progression and regeneration.
Asaf Vivante
Asaf Vivante is an Israeli pediatric nephrologist who directs Pediatrics B at Sheba Medical Center, is an associate professor at Tel Aviv University, and researches genetic kidney disease.
Bernardo Rodríguez‐Iturbe
Bernardo Rodríguez-Iturbe, also known as Bernardo Rodriguez-Iturbe, is a Venezuelan nephrologist at the Hospital Universitario de Maracaibo known for work on poststreptococcal glomerulonephritis and salt-sensitive hypertension.
Brad H. Rovin
Brad H. Rovin is an American nephrologist at Ohio State Wexner Medical Center specializing in lupus nephritis and IgA nephropathy; he led the AURORA 1 and PROTECT trials.
Bruce A. Julian
Bruce A. Julian is an American nephrologist at the University of Alabama at Birmingham known for research on IgA nephropathy and for establishing that it runs in families.
Carl Erik Mogensen
Carl Erik Mogensen (C. E. Mogensen), born in 1938, is a Danish nephrologist and professor emeritus at Aarhus University known for establishing microalbuminuria as a predictor of diabetic kidney disease.
Carla Nester
Carla Nester is an American pediatric and adult nephrologist at the University of Iowa specializing in complement-mediated kidney disease, and senior author of the 2025 VALIANT trial of pegcetacoplan in C3 glomerulopathy.
Charles E. Alpers
Charles E. Alpers is an American physician-scientist and nephropathologist at the University of Washington, known for research on kidney injury, diabetic kidney disease, and glomerular disease classification.
Christoph Wanner
Christoph Wanner is a German nephrologist at the University Hospital of Würzburg who led the 4D and EMPA-KIDNEY trials and presided over the European Renal Association.
Clark D. West
Clark D. West (1918–2014) was an American pediatric nephrologist at Cincinnati Children's Hospital who pioneered complement research in kidney disease and led its nephrology division for 36 years.
Claudio Ponticelli
Claudio Ponticelli (1936–2026) was an Italian nephrologist in Milan whose randomized trials of methylprednisolone and chlorambucil in membranous nephropathy, published from 1984, produced the Ponticelli regimen.
Curtis B. Wilson
Curtis B. Wilson (1936–2013) was an American physician-scientist and professor emeritus at The Scripps Research Institute, known for the first comprehensive clinical description of anti-GBM antibody-induced glomerulonephritis.
Daniel Cattran
Daniel C. Cattran is a Canadian nephrologist and University of Toronto professor who chairs the Toronto Glomerulonephritis Registry and co-led the MENTOR trial establishing rituximab for membranous nephropathy.
David J. Salant
David J. Salant is a South African–trained nephrologist at Boston University whose 2009 discovery of the PLA2R antigen turned membranous nephropathy diagnosis from biopsy to blood test.
David S. Baldwin
David S. Baldwin (1921–2013) was an American physician-scientist in nephrology at NYU School of Medicine and Bellevue Hospital, known for studies of glomerular disease, drug-induced interstitial nephritis, and poststreptococcal glomerulonephritis.
Detlef Schlöndorff
Detlef Schlöndorff (1942–2019) was a German-born nephrologist known for research on chemokines and inflammatory kidney disease, and editor-in-chief of Kidney International from 2012 to 2017.
Dick de Zeeuw
Dick de Zeeuw (born 1951 in The Hague) is a Dutch clinical pharmacologist and professor at the University Medical Center Groningen who led major diabetic kidney disease trials.
Dontscho Kerjaschki
Dontscho Kerjaschki is an Austrian nephropathologist and emeritus professor at the Medical University of Vienna, known for podocyte biology, membranous glomerulonephritis, and discovering lymphangiogenesis in the kidney.
Edmund J. Lewis
Edmund J. Lewis (1936–2023) was an American nephrologist who directed nephrology at Rush in Chicago and led the Collaborative Study Group's defining diabetic kidney disease trials.
Eric G. Neilson
Eric G. Neilson is an American nephrologist and physician-scientist, dean of Northwestern University Feinberg School of Medicine since 2011, known for research on fibroblasts in organ scarring and kidney inflammation.
Fernando C. Fervenza
Fernando C. Fervenza, also published as Fernando Fervenza, is a Brazilian-trained nephrologist and Mayo Clinic professor who led the MENTOR trial of rituximab for membranous nephropathy.
Frank B. Cortazar
Frank B. Cortazar is an American nephrologist specializing in vasculitis and glomerular disease who founded the New York Nephrology Vasculitis and Glomerular Center in 2019.
George A. Kaysen
George Alan Kaysen was an American nephrologist and physician-scientist at UC Davis and the VA, known for reframing low albumin in dialysis patients as inflammation rather than malnutrition.
Gerald B. Appel
Gerald B. Appel is an American nephrologist at Columbia University, Co-Director of Clinical Nephrology, who directs its Glomerular Kidney Disease Center and led a 2005 NEJM lupus nephritis trial.
Giancarlo Viberti
Giancarlo Viberti is an emeritus professor of diabetes at King's College London who established microalbuminuria as a predictor of diabetic kidney disease and led landmark drug trials.